Eastgate Biotech Corp Stock Return On Asset
| ETBIDelisted Stock | USD 0 0.00 0.00% |
Eastgate Biotech Corp fundamentals help investors to digest information that contributes to Eastgate Biotech's financial success or failures. It also enables traders to predict the movement of Eastgate Stock. The fundamental analysis module provides a way to measure Eastgate Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Eastgate Biotech stock.
Eastgate |
Eastgate Biotech Corp Company Return On Asset Analysis
Eastgate Biotech's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Eastgate Biotech Corp has a Return On Asset of 0.0. This is 100.0% lower than that of the Healthcare sector and about the same as Pharmaceuticals (which currently averages 0.0) industry. The return on asset for all United States stocks is 100.0% lower than that of the firm.
Eastgate Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Eastgate Biotech's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Eastgate Biotech could also be used in its relative valuation, which is a method of valuing Eastgate Biotech by comparing valuation metrics of similar companies.Eastgate Biotech is currently under evaluation in return on asset category among its peers.
Eastgate Fundamentals
| Operating Margin | (74.40) % | |||
| Current Valuation | 18.92 M | |||
| Shares Outstanding | 2.06 B | |||
| Price To Earning | (0.10) X | |||
| Price To Sales | 1.49 X | |||
| EBITDA | (3.55 M) | |||
| Net Income | (2.98 M) | |||
| Cash And Equivalents | 4.91 K | |||
| Total Debt | 1.67 M | |||
| Current Ratio | 0.02 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (389.48 K) | |||
| Earnings Per Share | (0.01) X | |||
| Beta | -3039.35 | |||
| Market Capitalization | 205.75 K | |||
| Retained Earnings | (14.63 M) | |||
| Working Capital | (1.94 M) | |||
| Current Asset | 167 K | |||
| Current Liabilities | 2.11 M |
About Eastgate Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Eastgate Biotech Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eastgate Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eastgate Biotech Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Consideration for investing in Eastgate Stock
If you are still planning to invest in Eastgate Biotech Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eastgate Biotech's history and understand the potential risks before investing.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |